CVE-2026-83362
Source GCVE Database
Not known to be exploited · CVSS 8.8 High.
Data as of 18 Nov 2026, 02:52 UTC
Thin evidence
One scorer or none| CNA (oracle) | CVSS 3.1 | 8.8 |
|---|
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 17 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 17 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Oracle CorporationOracle Purchasing | Affected
| Fixed in– |
AI-suggested
Oracle has released patches for this vulnerability as part of the November 2026 Critical Security Patch Update. Customers using Oracle E-Business Suite versions 12.2.3 through 12.2.15 are strongly advised to apply these patches promptly to remediate the vulnerability. Oracle emphasizes the importance of staying on actively-supported versions and applying security patches without delay to prevent exploitation.
Description
A vulnerability in the Oracle Purchasing product of Oracle E-Business Suite versions 12.2.3 through 12.2.15 allows a low privileged attacker with network access via HTTP to compromise the product. The vulnerability has a CVSS 3.1 base score of 8.8, indicating high severity with impacts on confidentiality, integrity, and availability. Successful exploitation can lead to full takeover of Oracle Purchasing. Oracle has released patches addressing this vulnerability in their November 2026 Critical Security Patch Update.